Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: January 27, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Carfentanil

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Carfentanil?

Carfentanil is an investigational drug.

There have been 8 clinical trials for Carfentanil. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2012.

The most common disease conditions in clinical trials are Tobacco Use Disorder, Depressive Disorder, and Depression. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), Yale University, and Johns Hopkins University.

There are four hundred and four US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Carfentanil
Neurobiology of Treatment Responses in MDDUniversity of UtahPhase 3
Imaging the Neurochemistry of Drug Addiction With PETYale UniversityN/A
FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 StudyYale UniversityPhase 1

See all Carfentanil clinical trials

Clinical Trial Summary for Carfentanil

Top disease conditions for Carfentanil
Top clinical trial sponsors for Carfentanil

See all Carfentanil clinical trials

US Patents for Carfentanil

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Carfentanil   Start Trial Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse Acura Pharmaceuticals, Inc. (Palatine, IL)   Start Trial
Carfentanil   Start Trial Transdermal dosage form Barr Laboratories, Inc. (Pomona, NY)   Start Trial
Carfentanil   Start Trial Self-expanding devices and methods therefor Intersect ENT, Inc. (Menlo Park, CA)   Start Trial
Carfentanil   Start Trial Drug device configured for wireless communication Pop Test Abuse Deterrent Technology, LLC (Cliffside Park, NJ)   Start Trial
Carfentanil   Start Trial Sublingual fentanyl spray INSYS DEVELOPMENT COMPANY, INC. (Chandler, AZ)   Start Trial
Carfentanil   Start Trial Combination dopamine antagonist and opiate receptor antagonist treatment of addictive behavior University of Maryland, Baltimore (Baltimore, MD)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Carfentanil

Drugname Country Document Number Estimated Expiration Related US Patent
Carfentanil Australia 2015274936 2034-06-09   Start Trial
Carfentanil Canada 2951563 2034-06-09   Start Trial
Carfentanil China 106456579 2034-06-09   Start Trial
Carfentanil European Patent Office 3151819 2034-06-09   Start Trial
Carfentanil World Intellectual Property Organization (WIPO) 2015191501 2034-06-09   Start Trial
Carfentanil Australia 2008338586 2027-12-18   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.